Thermo Fisher Scientific Inc. (BMV:TMO)

Market Cap	3.21T
Revenue (ttm)	876.41B
Net Income (ttm)	133.08B
Shares Out	n/a
EPS (ttm)	348.43
PE Ratio	24.10
Forward PE	18.94
Dividend	31.40 (0.39%)
Ex-Dividend Date	Mar 14, 2025

Volume	n/a
Average Volume	392
Open	8,038.80
Previous Close	8,038.80
Day's Range	8,038.80 - 8,038.80
52-Week Range	7,983.04 - 12,500.00
Beta	0.87
RSI	40.74
Earnings Date	n/a

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: TMO

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD